Real-time enrollment status for this hepatitis b, chronic clinical trial
Current Status
Recruiting
Checked: September 2, 2026 at 10:15 AM UTC
| NCT Number | NCT07654283 |
| Recruiting Status | Recruiting |
| Condition | Hepatitis B, Chronic |
| Phase | PHASE2 |
| Target Enrollment | 70 participants |
| Active Locations | 4 sites in the US |
| Sponsor | AusperBio Therapeutics Inc. |
| Last Updated on CT.gov | August 26, 2026 (1 week ago) |
As of September 2, 2026: Clinical trial NCT07654283 is currently recruiting participants. This phase2 study for hepatitis b, chronic is actively seeking new participants at 4 locations across the United States. The study is sponsored by AusperBio Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07654283 is actively recruiting participants as of September 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07654283 was last updated 1 week ago (August 26, 2026). HelloStudys verifies this status automatically.